One question we get asked often is “what can I do to support my friend or loved one during a cancer diagnosis?” The answer is really dependent on the stage of life however, we found this amazing website that has great articles and links to products and ideas that would be extremely helpful for your…Details
This new JScreen initiative offers at-home testing for more than 60 cancer susceptibility genes associated with hereditary risks for breast, ovarian, prostate, colorectal, skin and many other cancers. JScreen, www.jscreen.org, a national public health initiative based out of Emory University School of Medicine’s Department of Human Genetics, adds yet another way to save lives with the launch of its CancerGEN testing initiative. This new JScreen initiative offers at-home testing for…Details
A new clinical coverage policy became effective July 1. July 8, 2021 A new clinical coverage policy, 1S-5 Genetic Testing for Susceptibility to Breast and Ovarian Cancer (BRCA), became effective on July 1, 2021. The BRCA test uses deoxyribonucleic acid (DNA) analysis to identify harmful mutations, such as BRCA1&2 (breast cancer gene), which can increase…Details
So wonderful to read through the BASSER Progress report! Gives me such hope for our children’s future. IN 10 YEARS By 2030, Basser will continue to improve our understanding of BRCA, allowing us to overcome chemotherapy resistance, develop new targeted therapies for mutation carriers, and have better medications for managing metastatic breast cancer. We also…Details
Abstract BACKGROUND Poly(adenosine diphosphate–ribose) polymerase inhibitors target cancers with defects in homologous recombination repair by synthetic lethality. New therapies are needed to reduce recurrence in patients with BRCA1 or BRCA2 germline mutation–associated early breast cancer. METHODS We conducted a phase 3, double-blind, randomized trial involving patients with human epidermal growth factor receptor 2 (HER2)–negative early…Details
Study: How breast cancer patients experience hormone therapy Summary: Side effects from hormone therapy are a common reason that many men and women with hormone receptor-positive breast cancer stop treatment early. Some people never start hormone therapy. This study asked patients about their experiences with hormone (or endocrine) therapy. The results suggest that there may…Details
By Madison Pitsch Published: Oct. 20, 2020 at 5:11 PM EDT https://www.1011now.com/2020/10/20/albion-mother-gets-genetic-testing-for-cancer-encourages-others-at-risk-to-do-so/ LINCOLN, Neb. (KOLN) -October is Breast Cancer Awareness Month. For those who are facing a family history of cancer diagnoses, there is a way to learn more about your own risks for cancer. Genetic testing, for people at high risk of cancer, can change the…Details
October Organization Highlight: Nothing Pink By Romy Fawaz October is known as international Breast Cancer awareness month! It recognizes anyone affected by breast cancer and seeks to increase awareness of the disease. This month we are highlighting Nothing Pink, a non-profit organization located in South Carolina and founded in 2015 by Kelly Kashmer. The organization is…Details
The researchers catalogued 3,893 variants of the gene implicated in cancer using CRISPR. Sukanya Charuchandra Nearly 4,000 genetic variants of BRCA1, a tumor-suppressing gene whose loss of function can lead to breast and ovarian cancer, have been functionally classified, according to a study published September 12 in Nature. These findings could help with ascribing cancer risk to…Details
Mathew Knowles, father of music superstars Beyonce and Solange, opens up on the Dr Oz show about his battle with breast cancer.
He details the symptom that led him to get a mammogram, and points out the staggering amount of breast cancer in his family history. To view the full interview, click here.